Latest Burnham Institute for Medical Research Stories
Sanford-Burnham Medical Research Institute (Sanford-Burnham) has entered into a collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., (OMJPI) to discover compounds for Alzheimerâ€™s disease and major psychiatric disorders. La Jolla, Calif.
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem.
Investigators at Sanford-Burnham Medical Research Institute have discovered that the natural compound sceptrin, which is found in marine sponges, reduces cancer cell motility (movement) and has very low toxicity.
An international team of investigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham, formerly Burnham Institute for Medical Research), Nijmegen Centre for Molecular Life Sciences and other organizations have discovered that TKS4, a protein implicated in cancer metastasis, also plays a significant role in Frank-Ter Haar syndrome (FTHS), a rare fatal disorder.
Investigators identify host factors that help multiple influenza strains thrive and could be targeted for new antivirals.
Peptide Delivers Anti-Cancer Compounds to Where They Can Do the Most Good.
New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria.
Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease.
- A transitional zone between two communities containing the characteristic species of each.